Coronavirus: China launches study into asymptomatic cases and shared immunity
- Residents of nine regions, including Wuhan, Beijing and Shanghai, to be sampled using both nucleic acid and antibody tests, state media reports
- Research ‘very important as it will help us to direct our countermeasures in the future’, molecular virologist says

The research will be conducted in six provinces, including Hubei which was the focus of the initial outbreak, as well as Beijing, Shanghai and Chongqing.
Health workers collected throat swabs and blood samples from about 900 people randomly selected from eight subdistricts of the city on Tuesday, Ding Gangqiang, head of the Wuhan epidemiological survey team, was quoted as saying.
“The purpose is to learn about the immunity level in communities and provide scientific support on how we should adjust our disease control strategies,” he said.
Professor Lu Hongzhou, a specialist in infectious diseases who heads the Shanghai Public Health Clinical Centre where Covid-19 patients are being treated, said he supported the research though the collection of samples had yet to start in the city.